CO6361894A2 - Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa - Google Patents

Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa

Info

Publication number
CO6361894A2
CO6361894A2 CO11067504A CO11067504A CO6361894A2 CO 6361894 A2 CO6361894 A2 CO 6361894A2 CO 11067504 A CO11067504 A CO 11067504A CO 11067504 A CO11067504 A CO 11067504A CO 6361894 A2 CO6361894 A2 CO 6361894A2
Authority
CO
Colombia
Prior art keywords
inhibitors
skin
acetilcolinesterase
compositions
clearing compositions
Prior art date
Application number
CO11067504A
Other languages
English (en)
Spanish (es)
Inventor
Stephen Alan Madison
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of CO6361894A2 publication Critical patent/CO6361894A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO11067504A 2008-12-10 2011-05-31 Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa CO6361894A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/332,002 US8247405B2 (en) 2008-12-10 2008-12-10 Skin lightening compositions with acetylcholinesterase inhibitors

Publications (1)

Publication Number Publication Date
CO6361894A2 true CO6361894A2 (es) 2012-01-20

Family

ID=42231319

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11067504A CO6361894A2 (es) 2008-12-10 2011-05-31 Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa

Country Status (8)

Country Link
US (1) US8247405B2 (OSRAM)
EP (1) EP2355790A2 (OSRAM)
JP (1) JP2012511532A (OSRAM)
CN (1) CN102245165A (OSRAM)
CO (1) CO6361894A2 (OSRAM)
MX (1) MX2011006254A (OSRAM)
WO (1) WO2010066639A2 (OSRAM)
ZA (1) ZA201104223B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090317341A1 (en) * 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
US8440237B2 (en) 2009-04-27 2013-05-14 Mary Kay Inc. Botanical anti-acne formulations
WO2011014649A1 (en) 2009-07-29 2011-02-03 Duke University Compositions and methods for inhibiting hair growth
JP2011105666A (ja) * 2009-11-19 2011-06-02 Kao Corp ドーパオキシダーゼ活性抑制剤及び美白剤
US20120122936A1 (en) * 2010-11-11 2012-05-17 Conopco, Inc., D/B/A Unilever Leave-on nonsolid skin conditioning compositions containing 12-[(12-hydroxyoctadecanoyl)oxy] octadecanoic acid
KR102092977B1 (ko) 2011-12-19 2020-03-24 마리 케이 인코포레이티드 피부톤 향상을 위한 식물 추출물의 조합물
US11446241B2 (en) 2013-07-29 2022-09-20 Attillaps Holdings Inc. Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
CA2917815C (en) 2013-07-29 2022-08-30 Attillaps Holdings Organophosphates for treating afflictions of the skin
KR102323049B1 (ko) 2014-03-10 2021-11-05 마리 케이 인코포레이티드 피부 라이트닝 조성물
PT3157534T (pt) 2014-06-19 2022-08-04 Attillaps Holdings Inibidores de acetilcolinestérase para o tratamento de condições da dermatológicas
KR102523360B1 (ko) * 2015-12-24 2023-04-18 주식회사 엘지생활건강 쉬잔데린 ａ를 포함하는 피부상태 개선용 조성물
CN111329774A (zh) * 2020-03-30 2020-06-26 香港科技大学 乙酰胆碱脂酶活性抑制剂的新应用
CN121445651A (zh) * 2026-01-05 2026-02-03 广州莱倩化妆品有限公司 一种控油、遮瑕粉底组合物及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA529379A (en) 1952-09-20 1956-08-21 Farbenfabriken Bayer Aktiengesellschaft Phosphonic ester
JPS57102810A (en) * 1980-12-16 1982-06-26 Jiro Isono Cosmetic
IL74497A (en) 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
JPH01174389A (ja) * 1987-12-29 1989-07-10 Hayashibara Biochem Lab Inc メラニン生成抑制物質の製造方法とそれを含有する色白剤
US5750542A (en) 1993-09-28 1998-05-12 Pfizer Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors
JP3415200B2 (ja) * 1993-06-30 2003-06-09 三省製薬株式会社 皮膚外用剤
DE19509663A1 (de) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
US5998423A (en) 1996-10-08 1999-12-07 Therasys, Inc. Methods for modulating melanin production
KR100344751B1 (ko) * 1999-12-08 2002-07-20 주식회사 삼양제넥스 멜라닌 합성 저해물질 및 그것을 함유하는 조성물
US20020192243A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers
US6967023B1 (en) * 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6436378B1 (en) * 2001-02-28 2002-08-20 Colgate-Palmolive Company Composition
US6875425B2 (en) 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods
JP2004262853A (ja) * 2003-03-03 2004-09-24 Kanebo Ltd 化粧料
JP2004359732A (ja) * 2003-06-02 2004-12-24 Ryukyu Bio Resource Kaihatsu:Kk 抗酸化剤
ES2384878T3 (es) * 2003-11-07 2012-07-13 Basf Beauty Care Solutions S.A.S. Uso cosmético de un extracto de la fruta de Schisandra chinensis
GB0403534D0 (en) * 2003-11-27 2004-03-24 Unilever Plc Stable detergent composition and process to prepare the same
JP4321769B2 (ja) * 2004-04-13 2009-08-26 Ｔｏｗａ Ｃｏｒｐｏｒａｔｉｏｎ 株式会社 抗ヒスタミン用組成物、アレルギ性鼻炎の予防および治療用組成物、花粉症の予防および治療用組成物およびじんま疹治療用組成物
US9186345B2 (en) * 2004-10-12 2015-11-17 Hakon Hakonarson Method of treating skin diseases
ITMI20042413A1 (it) * 2004-12-17 2005-03-17 Indena Spa Processo per la preparazione di galantamina bromidrato
KR100794360B1 (ko) * 2005-07-01 2008-01-15 주식회사 참 존 항염 및 항알레르기 효과를 갖는 문주란 추출물을함유하는 화장료 조성물
US7250158B1 (en) 2006-03-30 2007-07-31 Conopco, Inc. Skin lightening agents, compositions and methods
US7247294B1 (en) 2006-03-30 2007-07-24 Conopco, Inc. Skin lightening agents, compositions and methods
US7270805B1 (en) 2006-03-30 2007-09-18 Conopco, Inc. Skin lightening agents, compositions and methods
FR2920089A1 (fr) * 2007-08-24 2009-02-27 Greentech Utilisation de 2.2-cyclolignanes comme agents promoteurs de la pigmentation de la peau ou des cheveux
BG110141A (en) * 2008-05-23 2009-12-31 "Софарма" Ад GALANTAMINE DERIVATIVES, METHODS FOR THEIR PREPARATION AND USE

Also Published As

Publication number Publication date
WO2010066639A2 (en) 2010-06-17
CN102245165A (zh) 2011-11-16
US20100143277A1 (en) 2010-06-10
WO2010066639A3 (en) 2011-01-20
ZA201104223B (en) 2012-09-26
JP2012511532A (ja) 2012-05-24
MX2011006254A (es) 2011-09-01
US8247405B2 (en) 2012-08-21
EP2355790A2 (en) 2011-08-17

Similar Documents

Publication Publication Date Title
MX2010006933A (es) Composiciones y metodos para reducir o prevenir la deshidratación de la piel.
MX2011006254A (es) Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa.
CO6761389A2 (es) Inhibidores de nampt y rock
CL2012000508A1 (es) Composicion para la aplicacion en cultivos agricolas al aire libre o invernaderos que comprende zeolita, y aditivos; uso de la composicion para aumentar el rendimiento de los cultivos agricolas.
NI201000103A (es) Formas cristalinas de dimetoxi docetaxel y metodo para preparar el mismo.
SV2009003307A (es) Quinazolinas para la inhibicion de pdk1
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
BRPI0917017B8 (pt) inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos
ECSP11010798A (es) 1,2,5-oxadiazoles como inhibidores de indolamina 2,3-dioxigenasa
ECSP088823A (es) Quinazolinas para la inhibición de pdk1
GT200900315A (es) Inhibición de arni de expresión de alfa-enac
CL2008002775A1 (es) Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
CR11548A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
MX356218B (es) Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c5.
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
CL2008003265A1 (es) Compuestos derivados de heterociclos nitrogenados, supresores de la produccion de colageno; composicion farmaceutica que comprende dichos compuestos; y su uso para prevenir y/o tratar la fibrosis y/o los tumores.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
CL2008002242A1 (es) Compuestos derivados de n-cicloalquil-n-carboxamida, tiocarboxamida, biciclicas o derivados de carboximidamida n-sustituida; composicion fungicida; y metodo para controlar los hongos fitopatogenos de los cultivos.
ATE509931T1 (de) Azaadamantanester- und carbamatderivate sowie anwendungsverfahren dafür
MX2009013043A (es) Antioxidante para alimentos.
EP2576536A4 (en) HEMATOPOETIC PROSTAGLANDIN D2 SYNTHASE INHIBITORS
ECSP088743A (es) Anticuerpos para egfl7 y métodos para su uso
ECSP12011837A (es) Derivados de pirazol que modulan la estearoil-coa-desaturasa
ATE510822T1 (de) Kaliumkanalinhibitoren

Legal Events

Date Code Title Description
FA Application withdrawn